Home/Filings/4/0001479290-19-000004
4//SEC Filing

McDowell Caryn Gordon 4

Accession 0001479290-19-000004

CIK 0001479290other

Filed

Jan 1, 7:00 PM ET

Accepted

Jan 2, 8:05 PM ET

Size

4.8 KB

Accession

0001479290-19-000004

Insider Transaction Report

Form 4
Period: 2018-12-31
McDowell Caryn Gordon
SVP, GC & Secretary
Transactions
  • Other

    Common Stock

    2018-12-31$17.11/sh+818$13,99616,818 total
Footnotes (1)
  • [F1]These shares were acquired by Ms. McDowell under the Issuer's 2014 Employee Stock Purchase Plan on December 31, 2018 in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Issuer

Revance Therapeutics, Inc.

CIK 0001479290

Entity typeother

Related Parties

1
  • filerCIK 0001674232

Filing Metadata

Form type
4
Filed
Jan 1, 7:00 PM ET
Accepted
Jan 2, 8:05 PM ET
Size
4.8 KB